Exploring a New Treatment Option for Advanced Biliary Tract Cancer Featuring CDX-1140, CAPOX, and Keytruda®
This webinar will cover key information about a new clinical trial for cholangiocarcinoma (bile duct cancer). The trial is looking at a drug called CDX-1140, which helps activate the immune system. It is being combined with chemotherapy (Capecitabine and Oxaliplatin) and Keytruda® to treat advanced biliary tract cancer. The webinar will explain how this trial works and who might benefit from it.
Recorded August 29, 2024
